Gout Flashcards
gout is
an arthritis associated w/ the presence of monosodium urate crystals (MSU) in synovial fluid or tissue leading to inflammatory reactions that causes intense pain, erythema and joint swelling
hyperuricemia
serum uric acid >7.0 mg/dL in M
serum level >6.0 mg/dL in F
should you tx asymptomatic pt with elevated serum uric acid concentration?
no
hyperuricemia secondary causes
- overproduction: purine rich diet, EToH, fructose, myeloproliferative disorders
-underexecretion: ethanol, cyclosporine, thiazides, furosemide, ethambutol, pyrazinamide, levodopa, niacin, low dose ASA, CTX agents, CKR
-wt, gender, HTN, etc.
non-pharm therapies
- correction or modification of underlying factors - SEE secondary causes
-meds, wt loss
-reduce dietary intake of purine-rich foods
-increase fluid intake
-decrease salt consumption
-joint rest/immobilization for 1-2d
-application of ice to affected area
for attacks of mild/moderate gout severity
6 of 10 on a 0-10 pain VAS particularly those involving 1 or a few small joints or 1 or 2 large joints
…monotherapy
in the absence of comorbidities
NSAID > colchicine > corticosteroids
must consider pt specific factors & commorbidities
NSAIDs
most effective if started w/i 1st 24hr of onset and continued for 24hr after resolution
NSAIDs should be avoided
active PUD
uncompensated CHF
uncontrolled HTN
severe renal impairment (<30-35ml/min)
NSAIDs are effective when given at full anti-inflammatory doses except
ASA and Tolmetin
COXibs
unclear risk/benefit ratio in acute gout
-option in pts w/ GI contraindications or intolerance to NSAIDs
colchicine
possesses no analgesic or uric acid-lowering effects
colchicine: acute dosing
1.2mg initially, then 0.6mg 1h later
total: 1.8mg over 1hr
colchicine: acute dosing contraindication
renal and hepatic dysfunction
elderly
frail
in severe renal impairment (CrCl <30mL/min) should not be repeated for 14 days
CrCl 30-80mL/min: no renal adj necessary
colchicine: place in therapy
-NSAID intolerance
-pts at risk for NSAID-induced gastropathy (active PUD)
-moderate CKD (w/ proper dose modifications)
-failed NSAID therapy
colchicine: ARDs & CIs
mostly GI (alopecia, malabsorption of vit b12, myopathy, myelosuppression)
-severe renal/hepatic impairment (neutropenia
-severe renal/hepatic impairment
- concomitant use of P-glycoprotein (P-gp) or strong CYP3A4 inhibitor in presence of renal or hepatic impairment
-severe cardiac / GI disease